Adrian Koh

Dr. Adrian Koh is a highly accomplished ophthalmologist, serving as a Founding Partner at Eye & Retina Surgeons, Director of Retinal Centre International, and Vice-President of the International Retinal Foundation. His extensive professional background includes fellowships at Moorfields Eye Hospital and the Jules Stein Eye Institute, and past roles such as Deputy Head of the Retina Research Group at SERI. Dr. Koh’s expertise covers a wide range of conditions, including degenerative macular diseases, inherited retinal diseases (like retinitis pigmentosa), and retinal vascular diseases. He is a diagnostic specialist who receives regional referrals for complex cases and is a leader in advanced treatments for macular degeneration and severe diabetic retinopathy, utilizing methods such as photodynamic therapy, anti-VEGF therapy, laser techniques (PASCAL system), and intravitreal adjunctive therapies.

Patricio Schlottmann

Dr. Patricio G. Schlottmann, MD, is an ophthalmologist and researcher in Buenos Aires, Argentina, serving as the Director of the Research Department at the Charles Research Center. He earned his MD from the University of Buenos Aires and completed specialized training and a research fellowship at Moorfields Eye Hospital in London. Dr. Schlottmann has demonstrated leadership by heading over 35 clinical research studies and founding the RIO LATAM initiative to enhance ophthalmology research collaboration across Argentina, Brazil, and Colombia. He is a prolific author, with over 60 publications and more than 4000 citations, and is actively involved as a peer reviewer, an editorial board member for prominent medical journals, and the vice president of the Argentinean Vitreous Retina Society.

Tai-Chi Lin

Dr. Tai-Chi Lin is the Director of the Vitreoretinal division at Taipei Veterans General Hospital and an Associate Professor at National Yang Ming Chiao Tung University. His primary research focuses on stem cell-based therapy and retinal diseases, and his surgical expertise includes macular, diabetic, complex retinal detachments, and cataract surgery. He is a prolific author, having published over 80 peer-reviewed manuscripts and delivered more than 50 talks internationally and in Taiwan. In addition, his dedication to rural public health over the past five years is notable, combining traditional screening with innovative telemedicine to screen diabetic patients for retinopathy, prevent blindness, and ease the burden on the local healthcare system.

Paul Mitchell

Prof. Paul Mitchell is an Emeritus Professor of Ophthalmology at the University of Sydney and a Member of the Centre For Vision Research at the Westmead Institute for Medical Research. He is a leading expert in macular degeneration, publishing extensively on the management of age-related macular degeneration (AMD), diabetic, and other vascular retinopathies, and co-authoring over 1,100 scientific publications. His contributions have been recognized with the 2004 Association of International Glaucoma Societies Award, his appointment as Trustee for the Clinical & Epidemiologic Research section of the Association for Research in Vision and Ophthalmology (ARVO) in 2007, and the Order of Australia (AO) in 2018 for his research.

Anthony Kwan
 

Associate Professor Anthony Kwan is a highly accomplished Vitreoretinal surgeon, currently serving as the Director of Vitreoretinal Service at the Queensland Eye Institute. He specializes in a wide range of retinal and macular diseases, including age-related macular degeneration and diabetic retinopathy, and performs cataract and vitrectomy operations. Prof. Kwan also has extensive research experience, particularly in experimental retinal transplantation, conducts clinical trials, and has secured grants from organizations like NHMRC and MDFA. Furthermore, he has held significant leadership roles, including Head of Ophthalmology at Mater Hospital and Chair of the Macular Disease Foundation Australia’s Research Committee since 2020.

Colin Tan

A/Prof Colin Tan is an Associate Professor of Ophthalmology at the Lee Kong Chian School of Medicine and Duke-NUS Medical School, and a Senior Consultant and Head of the Fundus Image Reading Center at the National Healthcare Group Eye Institute. His distinguished career includes a Fellowship in Medical Retina and Retinal Imaging and is marked by substantial academic contributions, having authored over 300 publications and several book chapters, and receiving major accolades like the National Medical Research Council Transition Award and the American Academy of Ophthalmology Achievement Award for his research on tomography angiography and optical coherence tomography.

Christiana Dinah

Dr Christiana Dinah is the macula service and research lead at Central Middlesex Hospital. She is the director for research and innovation at LNWH and the director for the newly established NIHR North West London Commercial Research Delivery Centre. She is also honorary senior clinical lecturer at Imperial College, London. She completed her medical retina fellowship at Moorfields Eye Hospital and then became a consultant at Central Middlesex Hospital, where she set up the award-winning research department. Dr Dinah has served as chief investigator or principal investigator in over 25 clinical trials, from Phase I to Phase IV. She was an expert member of the NICE diabetic retinopathy guidelines committee published in 2024 and is a member of Council of the Oxford Ophthalmological Congress. Her research interests are in AMD and retinovascular diseases, and she is passionate about patient-centric research design and inclusion in clinical research.

Timothy Lai

Prof. Timothy Lai, currently Clinical Professor (Honorary) at CUHK and Director of the 2010 Retina and Macula Centre, Hong Kong, specializes in the medical and surgical management of various retinal diseases. His significant academic career is marked by over 300 publications, a Scopus h-index of 69, and being named the world’s no.1 expert in choroidal neovascularization by Expertscape in 2022 and 2023. Prof. Lai’s international recognition is further evidenced by prestigious awards like the APAO Nakajima Award and his extensive leadership roles, including Vice President of the APVRS and President of the HKVRS, alongside service on over 10 international ophthalmic journal editorial boards.

Andrew Chang
 

Professor Andrew Chang is a prominent Australian ophthalmologist and vitreoretinal surgeon who serves as the Medical Director of the Sydney Retina Clinic and the Head of Ophthalmology at the Sydney Eye Hospital. He graduated from the University of Sydney Medical School, earned a PhD for retinal research conducted in both Australia and the USA, and completed advanced retinal fellowships at the Royal Victorian Eye and Ear Hospital. Highly active in academia and health policy, he holds a Conjoint Professorship at UNSW, acts as a clinician advisor to the Australian Department of Health and the TGA, and holds prominent international leadership roles including Secretary General of the Asia-Pacific Vitreoretinal Society. For his extensive contributions to blindness prevention, clinical research, and ophthalmic education, Professor Chang was appointed a Member of the Order of Australia (AM).

I-Van Ho

Professor I-Van Ho is a highly qualified Vitreoretinal Surgeon and Macular Disease Specialist based in Australia, holding an MBBS, MPH, and PhD. After completing his ophthalmology residency at the Sydney Eye Hospital, he undertook advanced international fellowship training in Canada and New York. He currently serves as a Professor of Ophthalmology at Macquarie University and is a senior consultant at the Sydney Eye Hospital, where he also directs the Vitreoretinal Fellowship program. His specialized clinical expertise focuses on small incision vitrectomy surgery, advanced retinal imaging, and the medical and surgical management of macular and vitreoretinal diseases. 

Nancy Holekamp
 

Nancy M. Holekamp, MD was Director of Retina Services at the Pepose Vision Institute in St. Louis, Missouri from 2011 to 2022. Prior, she was Professor of Clinical Ophthalmology at the Washington University School of Medicine in St. Louis, Missouri from 2009 to 2020. She has been a principal investigator in more than 40 national clinical trials dealing with age-related macular degeneration, retinal vascular occlusion, and diabetic retinopathy. Her efforts in research have resulted in over 100 peer-reviewed publications, 22 book chapters, and more than 150 speaking invitations. She was Visiting Professor at Roche in 2023 and is now a Principal Global Medical Science Lead at Roche.

Yi-Ting Hsieh

Yi-Ting Hsieh, MD, PhD is Clinical Professor at National Taiwan University and Chair of Ophthalmology at NTU Hospital, Hsin-Chu Branch. His work bridges cutting-edge research and clinical care, focusing on diabetic retinopathy, vitreomacular interface diseases, age-related macular degeneration, hydroxychloroquine retinopathy, ocular imaging, and the application of artificial intelligence. He has published over 180 SCI-indexed journal articles and received several international honors, including the Best Free Paper Award (APVRS, 2018), Best Video Award (APVRS, 2019), and Best Free Paper Award (APAO, 2021). Dr. Hsieh has served as faculty at numerous international congresses, including the Retina World Congress, APAO, and APVRS. As the inventor of the AI diagnostic platforms VeriSee DR and VeriSee AMD, he has advanced the application of artificial intelligence in ophthalmology.